Following the administration of FY26⋅Cl to Hepa1–6-Per2-luc tumour-bearing mice at ZT6, the tissue [Os] concentrations varied as a function of dose at 6 h, in the tumours in each flank and in liver (Fig. 7). This evidence concerns the gene PER2 and neoplasm.